Related Experiment Video

Updated: Mar 17, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.6K

Socioeconomic Factors Impact Inpatient Mortality in Pediatric Lymphoma Patients

Yana Puckett1, Anh Ta2

  • 1Surgery, Texas Tech University Health Sciences Center.

Cureus
|July 20, 2016
PubMed

Insights

Socioeconomic factors and medical conditions significantly impact pediatric lymphoma inpatient mortality. Identifying these risk factors can improve survival rates for children with lymphoma.

Area of Science:

  • Pediatric Oncology
  • Health Services Research
  • Epidemiology

Background:

  • Pediatric lymphoma is a serious diagnosis with significant inpatient mortality.
  • Understanding risk factors is crucial for improving outcomes in pediatric cancer patients.

Purpose of the Study:

  • To identify risk factors for inpatient mortality in pediatric patients diagnosed with lymphoma.
  • To analyze the influence of medical and socioeconomic factors on pediatric lymphoma mortality.

Main Methods:

  • Cross-sectional study utilizing the 2012 Healthcare Cost and Utilization Project Kids' Inpatient Database (HCUP KID).
  • Analysis included pediatric patients aged 1-18 diagnosed with lymphoma.
  • Statistical analysis employed Chi-square and independent t-tests.

Main Results:

  • A total of 2,908 pediatric lymphoma patients were analyzed; 1.2% experienced inpatient mortality.
  • Multiple chronic conditions (≥4), lower median household income (<$47,999), and need for major procedures were associated with increased mortality.
  • Specific comorbidities like congestive heart failure, renal failure, coagulopathy, metastatic disease, and electrolyte abnormalities were linked to higher inpatient mortality.

Conclusions:

  • Pediatric lymphoma mortality is influenced by both a child's medical condition and their socioeconomic status.
  • Addressing socioeconomic disparities may be key to reducing mortality in pediatric lymphoma patients.
Abstract

Keywords:
chronic illnesslymphomapediatric cancerpediatric malignanciessocioeconomic status

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

808

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812